Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
New CGM Targets – Pregnant Women and High-Risk Patients
Long-Term Increases in Sugary Drink Consumption & Diabetes Risk
Dapagliflozin and its Heart Failure Benefit
MOST POPULAR ARTICLES OF THE MONTH
#1 Updated Consensus Report on Diabetic Nutrition Therapy
Editor's Note
Last week we let you know that one of our most read articles for 2019 was about the use of CGM. The benefits in that article were overwhelming, and now medical researchers are taking the use to a new level.
Nour Salhab, Pharm.D. Candidate, USF College of Pharmacy, has found some new information on two very important groups of people who could benefit immensely from CGM technology.
Dave Joffe
Editor-in-chief
TOP STORIES -- Diabetes News and Research
Getting patients to new standard CGM targets will prevent complications and hypoglycemia.
What does consuming consistently increasing amounts of both sugary and artificially sweetened beverages mean for patients’ long term health?
Could a newer diabetes medication provided clinicians with an alternative when managing heart failure?
About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.